G 1 /S-phase boundary and suggest that a Max-associated protein complex contributes to the serum response.
Cellular responses to external growth stimuli involve complex signal transduction pathways which lead to changes in the expression of genes needed for DNA synthesis and cell division. The carbamoyl-phosphate synthase (glutamine-hydrolyzing)/aspartate carbamoyltransferase/dihydroorotase (cad) gene encodes a trifunctional enzyme which catalyzes the first three steps in the de novo synthesis of pyrimidines (21) . In mammalian cells, the levels of both CAD enzymatic activity and cad mRNA correlate with the proliferative state of the cell. For example, the endogenous cad mRNA level increased approximately 10-fold at the G 1 /S transition following serum stimulation of quiescent cells (58) . Nuclear run-on assays demonstrate a 3-to 10-fold increase in the rate of cad transcription after serum stimulation, suggesting that a significant portion of growth-dependent regulation occurs at the transcriptional level (44, 58) . In accordance with a model of transcriptional regulation, the activity of a 164-bp region of the cad promoter fused to a reporter gene increases 15-fold at the G 1 /S-phase boundary in a serum starvation/stimulation assay (50) . To identify the factor(s) which coordinates cad expression with the growth responsiveness of the cell, we have analyzed the requirements for accurate cad transcription in cultured cells and in cell extracts.
The sequences of the Syrian hamster cad promoter that support growth-responsive transcription extend from positions Ϫ81 to ϩ83 (50), relative to the major start site of transcription (22) . In a footprinting assay with HeLa nuclear extract, three major regions of the Ϫ81/ϩ83 promoter are protected from DNase I cleavage (22) . The first region binds the transcription factor Sp1 at two sites, one near Ϫ70 and the other near Ϫ49 (22, 34) . Sp1 binding is critical for basal promoter activity, and the proximal Sp1 site positions the start site of transcription from this TATA-less promoter (35) . The second major protected region binds a ubiquitous activator protein, designated Honk, at Ϫ17 (35) . Preliminary results suggest that neither the Sp1 sites nor the Honk site play a role in growth-dependent regulation; that is, promoter constructs mutated at these sites still display substantial increases in cad transcription at the G 1 /S-phase boundary (49a) . A third region of the cad promoter that binds protein in a HeLa footprinting assay spans the sequence from ϩ55 to ϩ75. In the center of these 21 nucleotides lies a palindromic sequence which matches the binding consensus for E-box-binding proteins such as USF (7), c-Myc, and Max (63) . Immediately adjacent to the protected region, between ϩ75 and ϩ83, lies an E2F-like site in which 7 of 8 bases match the E2F-binding consensus (51, 53) .
USF, c-Myc, Max, and the E2F family of proteins share a common structural feature, the helix-loop-helix domain, which mediates dimerization between functional protein partners. The E2F gene family of transcription factors includes E2F1, E2F2, E2F3, E2F4, DP1, and DP2. On the basis of cooperativity in DNA-binding and transactivation assays, it is believed that E2F1 (or E2F2, E2F3, or E2F4) heterodimerizes with DP1 (or DP2) to form E2F activity at the DNA sequence TTTSSCGC (where S is C or G) in viral and cellular genes (4, 27, 30, 36) . Examples of E2F-regulated genes include the dihydrofolate reductase gene (dhfr) (49, 62) , the thymidine kinase gene (17, 42) , and B-myb (38, 39) , all of which are induced at the G 1 /S-phase boundary. The family of proteins which recognize a hexanucleotide sequence known as an E box (CANNTG, where N is A, C, G, or T) include the adenovirus major late transcription factors USF/MLTF (24), TFE3 (5), TFEB (13) , and AP-4 (29); the heterodimeric transcriptional activator c-Myc:Max and the homodimeric transcriptional re-pressor Max:Max (1, 10, 37, 55) ; and the transactivation-incompetent, differentiation-specific complexes Mad:Max (2, 3) and Mxi1:Max (67) .
An abundance of evidence has amassed in recent years implicating members of the E2F and E-box families, specifically E2F1 and c-Myc, as key regulators of proliferation and growth cycle progression (for reviews, see references 20, 23, 46, and 48) . Both contribute to the transformation of primary rat embryo fibroblasts when overexpressed in culture (40, 61) . Both are down-regulated upon growth arrest (15, 62, 65) , and in some cell types, inducing expression of c-Myc (18) or E2F1 (31) ectopically in quiescent cells is sufficient to cause entry into the S phase. Conversely, inhibiting c-myc expression via antisense oligonucleotides or antisense transcripts prevents mitogen-treated cells from entering the S phase, providing further evidence that c-Myc plays an important role in progression through the G 1 phase of the growth cycle (26, 56) . In two model systems in which the growth cycle has been well characterized, serum induction of quiescent cells (33, 57, 64) and partial hepatectomy (47) , c-Myc expression increases prior to the G 1 restriction point and returns to a somewhat lower level that remains invariant through the rest of the cycle. Levels of E2F1 increase later at the G 1 /S-phase boundary (28, 62) , which is consistent with the role of this protein as a direct activator of genes, such as dhfr, that are needed for DNA synthesis. A few potential c-Myc target genes have been identified, including the ␣-prothymosin gene (18) , ECA39 (8), p53 (59) , and the ornithine decarboxylase gene (odc) (6) . Some of these c-Mycactivated genes are associated with cellular proliferation but cannot be placed into a single category on the basis of their temporal pattern of expression through the cell growth cycle.
To more precisely delineate the factors which regulate cad expression, we investigated the potential role of both the E box and putative E2F site in activating G 1 /S-phase transcription from the cad promoter. Here, we show that the E box is both necessary and sufficient for growth-dependent expression of cad and that the E2F-like site is dispensable. By use of both in vitro and in vivo analyses, we address the potential contribution of USF, c-Myc, and Max to cad transcription at the G 1 / S-phase boundary.
MATERIALS AND METHODS
Plasmids. Standard cloning techniques were used for all plasmid constructions (60) . cad reporter plasmids contain promoter fragments cloned upstream of the luciferase cDNA in the vector pGL2Basic (Promega). Construction of cadϪ81/ ϩ83 and cadϪ81/ϩ26 has been described previously (35) . The construct cadϪ81/ ϩ55 was created by blunt-end ligation of EspI-HindIII-digested cadϪ81/ϩ83. The construct cadE2Fmt was created by inserting a double-stranded oligonucleotide which contains a blunt 5Ј end, a mutation at the E2F-like site, and a 3Ј HindIII cohesive end into the PmlI-HindIII sites of cadϪ81/ϩ83. The sequence of the top strand of the oligonucleotide reads 5Ј-GTGGACCAACCCCTATATG gggatctaagta-3Ј, with wild-type cad promoter sequences indicated by capital letters, mutant bases indicated by boldface type, and vector sequences indicated by lowercase letters. The construct cadEboxmt was generated from cadϪ81/ϩ83 by PCR with pGLprimer1 (Promega) to prime synthesis of the coding (top) strand and a 56-base oligonucleotide spanning from cad ϩ50 to 5 bases beyond the HindIII site in pGL2Basic to prime synthesis of the noncoding (bottom) strand. The latter primer introduced an E-box mutation (CCACGTGG to ACTGCAGG). The amplified fragment was inserted into the KpnI-HindIII sites of pGL2Basic. The constructs cadϩ26/Ebox and cadϩ26/Emt were created by inserting a doublestranded oligonucleotide which corresponds to cad promoter sequences ϩ55/ ϩ75 and contains filled-in BglII ends into the filled-in HindIII site of cadϪ81/ϩ26. The top strands of the wild-type and mutant oligonucleotides read as follows:
5Ј-gatctAGCGAGCCACGTGGACCAACTa-3Ј (wild type, Ebox) 5Ј-gatctAGCGAGACTGCAGGACCAACTa-3Ј (mutant, Emt)
The same blunt-ended oligonucleotides were inserted into the SmaI site of cadϪ81/ϩ26 to create Ebox/cadϩ26 and Emt/cadϩ26. The dhfr reporter plasmid pWTluc has been described previously (49) .
The TI construct contains a TATA box and an initiator element cloned into pGL2Basic (50) . The construct STI was created by inserting cad promoter sequences Ϫ75/Ϫ43, which contain two consensus Sp1-binding sites (22, 34) , into the SmaI site of TI. To create S/Ebox/TI, the ϩ55/ϩ75 (Ebox) oligonucleotide was inserted into the BglII site of the plasmid STI. The STI/Ebox plasmid was created by inserting the same oligonucleotide, which was first blunt ended with Klenow fragment, into the HindIII site of plasmid STI. Each reporter construct was verified by sequencing.
The mouse sarcoma virus long terminal repeat (LTR) drives expression of wild-type and mutant human c-myc cDNAs which were cloned into the EcoRI site of a plasmid originally derived from a Bluescript (Stratagene) vector (37) . The LTR construct expresses no cDNA. The LTR-Myc⌬Br construct expresses a derivative of human c-Myc lacking amino acids 353 to 367 in the basic DNAbinding domain (10) . The LTR-Myc⌬TAD construct expresses a human c-Myc mutant lacking amino acids 44 to 170 in the transactivation domain. It was created by removing a 413-bp PstI fragment from the wild-type human c-myc cDNA in plasmid LTR-Myc. Numbering refers to the amino acid sequence of human c-myc (66) .
Cell culture and transfections. NIH 3T3 cell cultures were maintained as described previously (50) . One day prior to transfection, 1. (50) . Cells were then growth arrested by replacing the maintenance medium (5% serum) with starvation medium (0.4% serum). After 2 days, the cells were stimulated to reenter the proliferative cell cycle by replacing starvation medium with stimulation medium (10% serum). Cells were harvested at specified times following serum stimulation and assayed for luciferase activity (50) . For 22-h time courses, cells were harvested at 2-h intervals following stimulation. For monitoring promoter activity during S phase only, cells were harvested at 0, 12, 14, and 16 h following serum stimulation. Transfection efficiencies typically ranged from 2 to 5% as determined by ␤-galactosidase assays (45) . Growth cycle progression was monitored by flow-cytometric analysis of propidium iodide-stained cells (62) . Each transfection was repeated at least twice with duplicate samples and multiple DNA preparations. Nuclear extract preparation. Nuclear extracts were prepared from NIH 3T3 cells, after serum starvation (0 h) and stimulation for 4, 8, or 12 h (3 ϫ 10 7 cells per time point), by a modification of a published method (16) . Cells were swollen in 500 l of RSB hypotonic buffer (19) supplemented with 0.5 mM dithiothreitol, 100 g of phenylmethylsulfonyl fluoride (PMSF) per ml, 1 g of orthovanadate per ml, and 10 g of leupeptin per ml. The swollen cells were supplemented with 0.5% (vol/vol) Nonidet P-40, and the nuclei were released by Dounce homogenization. Nuclei were pelleted at 4,000 ϫ g for 5 min and washed briefly with RSB to remove residual Nonidet P-40. Nuclear proteins were extracted at 4ЊC for 30 min in 100 l of buffer C (16) supplemented with 0.5% deoxycholate, 1.0% octyl-␤-glucoside, 1 g of orthovanadate per ml, and 10 g of leupeptin per ml. After dialysis against buffer D (16) for 1 h at 4ЊC, nuclear extracts were quantitated by the Bradford assay (Bio-Rad) and stored at Ϫ70ЊC.
Electromobility shift assays. Electromobility shift assays were performed as described previously (41) with the following modifications. In a total volume of 18 l, 6 to 12 g of nuclear extract, 2 g of sonicated salmon sperm DNA, 11 l of binding buffer (7.1 mM N-2-hydroxyethylpiperazine-NЈ-2-ethanesulfonic acid [HEPES; pH 7.0], 3.6 mM MgCl 2 , 100 mM KCl, 5.7% glycerol, 0.03% Nonidet P-40), and specific competitor DNA (when indicated) were incubated together for 10 min at room temperature. When specified, antibodies were then added to individual reactions, and the mixtures were incubated for an additional 10 to 20 min at room temperature. Oligonucleotide probes (0.5 ng of DNA per reaction) which had been end labeled with [␥- (60) were added to the reactions, and incubation was continued at room temperature for 10 to 20 min. The reaction mixtures were then electrophoresed for 90 min on a 4% polyacrylamide gel (29:1 acrylamide/bisacrylamide) which had been preelectrophoresed for 30 to 60 min. The gel and electrophoresis buffer was 22.5 mM Tris-morpholinepropanesulfonic acid (MOPS; pH 7.0)-0.5 mM EDTA. Gels were dried prior to autoradiography. The amount of antibody used in competition experiments was as follows: 1 l of dilute (1:100 in binding buffer) anti-human USF antiserum from rabbits (gift from R. Roeder), or 2 g of anti-human c-Myc antiserum from rabbit 1537-15 (gift from R. N. Eisenman; raised against the C terminus), anti-human Max antiserum from rabbit 8711A (gift from R. N. Eisenman; raised against the entire protein), anti-human c-Myc monoclonal antibody from mice (Santa Cruz Biotechnology), anti-human Max from rabbits (Santa Cruz Biotechnology), or normal rabbit serum pooled from three individual preimmunized rabbits (gift of the R. Burgess laboratory).
Western immunoblot analysis. Growth cycle-staged NIH 3T3 cells (6 ϫ 10 sample (2 ϫ 10 6 cells) was resolved by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) under reducing conditions on a 10% polyacrylamide gel (29:1 acrylamide/bisacrylamide) by standard techniques (60) . Proteins were transferred to nitrocellulose and probed with anti-human Myc antiserum 1537-15 (gift from R. N. Eisenman) at 1:500 and then with a peroxidase-conjugated anti-rabbit secondary antibody from goats (Boehringer-Mannheim). Proteins were detected by enhanced chemiluminescence (Kirkegaard & Perry). The same blot was then probed with either anti-human USF antiserum (gift from R. Roeder) at 1:10,000 or anti-human Max antiserum 8711A (gift from R. N. Eisenman) at 1:5,000; this was followed by probing with the same secondary antibody as above and enhanced chemiluminescence detection.
RESULTS
Identification of the growth-responsive element in the cad promoter. To better localize the growth-responsive element within the Ϫ81/ϩ83 promoter, we examined the activity of a cad construct whose 3Ј terminus lay at ϩ55 (cadϪ81/ϩ55) in a growth response assay. The luciferase reporter construct was transfected into a growing population of cells, which were then serum starved to induce growth arrest. When stimulated with serum-rich medium, the cells synchronously progress through one growth cycle. Figure 1 shows that unlike the Ϫ81/ϩ83 fragment, the Ϫ81/ϩ55 region of the cad promoter does not confer growth-dependent regulation to the reporter gene. The truncated promoter provided at least as much basal transcriptional activity as did the wild-type promoter in quiescent cells, as a result of the presence of two intact Sp1 sites which have been shown previously to be essential for promoter activity in vitro and in vivo (35) . In contrast to the cadϪ81/ϩ83 construct that was activated 15-fold in more than three independent experiments, the Ϫ81/ϩ55 promoter was activated only 2-to 3-fold at the G 1 /S-phase boundary. These results indicate that the region downstream of ϩ55 contains an element critical for growth responsiveness but dispensable for overall promoter activity.
Potential recognition sequences for two classes of transcription factors lie between cad promoter sequences ϩ55 and ϩ83. To examine the contribution of each sequence to the growthresponsiveness of cad, the E2F-like site at ϩ75 and the E box at ϩ65 were independently mutagenized within the context of the Ϫ81/ϩ83 promoter background. The cad E2F-like site was changed to a sequence which abolished E2F binding to and growth-dependent regulation of the murine dhfr promoter (49) . Similar to the Ϫ81/ϩ83 promoter, the activity of the cadE2Fmt construct began to increase at 8 h following stimulation and climbed to a clear peak within S phase. Although the induction level in S phase was lower for the cadE2Fmt construct than it was for the wild-type construct, the overall shape of the two serum response curves was similar. In contrast, substituting 5 of 8 bases at the extended E-box sequence, CCACGTGG, abolished the characteristic rise in transcriptional activity that begins 8 h following serum stimulation. Induction of the cadEboxmt construct was nearly indistinguishable from that of the nonresponsive Ϫ81/ϩ55 deletion mutant throughout G 1 phase and at the G 1 /S-phase transition. The E-box mutation did not adversely affect basal promoter activity, however, since the absolute level of promoter activity in quiescent cells was at least as great as the activity of the wildtype construct. Comparison of the general shape of individual serum response curves established a clear difference between the serum inducibility of the cadEboxmt and cadE2Fmt promoters. These data implicate a more critical role for the E box than for the E2F-like sequences in mediating serum-induced transcription from the cad promoter. However, since the E2F mutation did significantly depress the level of induction during S phase, the possibility exists that E2F cooperatively interacts with the more critical regulatory factors at the adjacent E-box motif.
The ؉55/؉75 region of the cad promoter is sufficient to confer growth responsiveness to a nonresponsive, minimal cad promoter. The cad sequences from Ϫ81 to ϩ26 constitute the minimal promoter region necessary and sufficient for accurate transcription initiation in vitro and in vivo (35) . While these promoter sequences provide strong basal transcriptional activity, they do not support growth-dependent transcription (Fig.  2) . To determine if the cad E-box region alone could confer growth responsiveness to this minimal cad promoter, a 21-bp Promoter induction is reported as the ratio of luciferase activity measured in cells harvested at the indicated times following serum stimulation relative to activity from the same construct in serum starved cells. The absolute level of luciferase activity measured in serum-starved cells was comparable for each construct within individual experiments and was 10-to 150-fold greater than the activity measured in mock-transfected cells. Data represent the average of 3 to 10 independent experiments. The standard error for each construct was greatest at the peak of induction. The percent standard error at the time of peak induction was 34% for cadϪ81/ϩ83, 16% for cadE2Fmt, 40% for cadEboxmt, and 29% for cadϪ81/ϩ55. The stages of the growth cycle are indicated above the graph and were determined by flow cytometry (data not shown).
VOL. 15, 1995 REGULATION OF cad AT THE G 1 /S TRANSITION 2529 oligonucleotide (cad sequences ϩ55/ϩ75) that contains the E box but excludes the E2F-like site was inserted downstream of cad sequences Ϫ81/ϩ26. In the resulting hybrid promoter (cadϩ26/Ebox), the ϩ55/ϩ75 region lies 36 bp downstream from the transcription start site, which is approximately 20 bp closer than in the cellular promoter. The cadϩ26/Ebox construct clearly exhibits nearly wild-type levels of regulated expression through the growth cycle (Fig. 2 ). An analogous hybrid promoter containing the ϩ55/ϩ75 region with a mutated E box (ACTGCAGG) was unresponsive at the G 1 /S-phase boundary (Fig. 3) , indicating that the E-box sequence CCA CGTGG is required for the growth-dependent increase in transcriptional activity. Likewise, the Ϫ81/ϩ55 promoter was rendered fully serum inducible at the G 1 /S-phase boundary by reintroduction of the E-box sequences but not the E2F-like sequences downstream (data not shown). Taken together with the deletion and mutagenesis studies above, these results indicate that the E box is both necessary and sufficient for increased transcription from the cad promoter at the G 1 /S-phase boundary. Furthermore, since the ϩ55/ϩ75 element alone conferred growth responsiveness, the E2F-like site appears dispensable for growth-dependent regulation of cad. The diminished inducibility of the cadE2Fmt construct relative to the wild type may indicate that base substitution at the E2F-like site altered sequences flanking the E box to those unfavorable for binding by E-box-binding proteins.
Several groups have demonstrated that multiple copies of the CACGTG sequence placed 5Ј to ϩ1 will activate transcription in proliferating cells, but the activity of these E-box-driven promoters was not examined during the transition from quiescence to a proliferative state. To determine if the cad E box could confer G 1 /S-phase activation when placed either upstream or downstream of the transcription start site, a variety of synthetic hybrid promoters were constructed (Fig. 3) . The maximum transcriptional activity observed for each promoter during the S phase of the growth cycle was compared with promoter activity in serum-starved cells. As described in Fig. 2 , the ϩ55/ϩ75 region of cad conferred considerable S-phase activation to the minimal cad promoter when it was inserted downstream of the transcription start site (cadϩ26/Ebox). In contrast, when the ϩ55/ϩ75 sequences were located upstream (Ebox/cadϩ26), approximately 20 bp 5Ј to the Sp1 sites in the Ϫ81/ϩ26 cad promoter, transcription from the resulting construct was induced about threefold during S phase, which was about half that observed when a single site was placed downstream. This modest level of induction is reminiscent of the gradual increase in activity from the simian virus 40 early promoter throughout the growth cycle (62) . Again, mutant E-box sequences had no effect when placed either upstream (Emt/cadϩ26) or downstream (cadϩ26/Emt). Similar results were observed when pieces of the cad promoter were reassembled in the context of a heterologous, synthetic promoter which contains only two Sp1 sites, a TATA box, and an initiator region (STI). Placing the cad ϩ55/ϩ75 sequence downstream of the start site in the STI promoter (STI/Ebox) resulted in greater S-phase activity than placing it upstream of ϩ1 (S/ Ebox/TI) did. Despite the inherant caveat of potentially suboptimal spacing between the several transcription factor-binding sites, a general trend did emerge. The cad E-box region conferred greater transcriptional activity in S phase when placed in a transcribed region of the promoter, as opposed to upstream of ϩ1.
Nuclear proteins bind cad ؉55/؉75 sequences in a growth cycle-dependent manner. Previous footprinting analysis has es-
FIG. 2. Induction of growth-regulated transcription from a hybrid cad promoter containing basal elements and the E-box region. (A) Schematic representation of cad reporter constructs. (B)
Graphical representation of the average induction of cad reporter activity through the growth cycle of NIH 3T3 cells. Cells were transiently transfected with the indicated reporter constructs and serum starved or stimulated as described in the legend to Fig. 1 . Data represent the average of 2 to 10 independent time course experiments. The standard error for each construct was greatest at the peak of promoter activity. The percent standard error at the time of peak induction was 34% for cadϪ81/ϩ83, 20% for cadϪ81/ϩ26, and 46% for cadϩ26/Ebox. tablished that nuclear proteins bind the ϩ55/ϩ75 region of the cad promoter in proliferating HeLa cells (22) . However, the identity of the DNA-bound proteins remained unknown. As a first step toward characterizing these proteins, we used growth cycle-staged extracts in an electrophoretic mobility shift assay to confirm that nuclear proteins could bind the ϩ55/ϩ75 region in NIH 3T3 cells. Figure 4A shows that three major protein complexes bound a radiolabeled ϩ55/ϩ75 probe in NIH 3T3 cells. A similar pattern of complex formation was observed in extracts from proliferating mouse Friend cells and human K562 cells, except that an additional complex (III) was observed when K562 extract was used (data not shown). Binding activity to the ϩ55/ϩ75 probe was barely detectable in quiescent NIH 3T3 cells and became more pronounced at 8 and 12 h following serum stimulation (Fig. 4A , leftmost five lanes), which closely correlates with levels of cad transcriptional activity. Complex formation was specifically inhibited by a 10-to 50-fold molar excess of unlabeled probe DNA or the entire Ϫ81/ϩ83 cad promoter fragment but not by analogous competitors containing the E-box mutation which abolished growth-dependent regulation of the cad promoter (Fig. 4A , lanes labeled wt 12, wtp 12, and mp 12). To control for protein quantitation in each extract, Sp1-binding activity to cad sequences Ϫ75/Ϫ43 was assayed (Fig. 4B) . As expected (43), Sp1-binding activity was invariant through the growth cycle of NIH 3T3 cells. These data indicate that the increased complex formation at cad sequences ϩ55/ϩ75 in staged extracts reflects an enhanced affinity of nuclear proteins for the cad E box as a function of the growth state of the cell.
To identify the proteins bound to the ϩ55/ϩ75 probe, we preincubated extracts with antibodies raised against specific E-box family members (Fig. 4A) . In each case, inhibition of DNA-protein complexes was specific to proteins bound to the cad E-box probe, since the antisera did not interfere with Sp1-DNA complex formation (Fig. 4B, panel 2) . Moreover, equal or greater amounts of preimmune serum had no effect on the E-box-bound complexes (data not shown), indicating that rabbit serum does not contain a general inhibitor of DNAprotein interactions. Antiserum specific for USF significantly blocked formation of complex II (Fig. 4A, lane labeled USF 8) ; similarly, anti-Max antibodies efficiently blocked formation of complex IV and reduced formation of complex I (Fig. 4A , lanes labeled Max 8 and Max Myc 8). Whether complex I or IV consists of Max homodimers or other Max partners cannot be ascertained from these data. Thus, our analysis confirmed that both USF and Max can recognize the cad E box, a result expected from consensus definitions for the DNA-binding specificities of these proteins in vitro (7, 63) .
Although we could detect growth-dependent binding of Max and USF by electrophoretic mobility shift assay, we could not detect c-Myc in NIH 3T3 extracts. To ensure that c-Myc was expressed in our NIH 3T3 cells and to determine the relative abundance of USF, c-Myc, and Max proteins through the growth cycle, Western analysis was performed with whole nuclear lysates prepared by more stringent extraction procedures from serum-starved and -stimulated NIH 3T3 cells (Fig. 5) . As expected, the levels of c-Myc protein were barely detectable in serum-starved NIH 3T3 cells (15, 33, 65) ; peak c-Myc expression occurred 8 h following serum stimulation, which is when cad transcription begins to increase in transfection experiments. USF was detectable at relatively constant levels in both quiescent and serum-stimulated cells. Max was also present throughout the growth cycle, as previously reported (9, 11; data not shown). Taken together with the results of the DNAbinding studies, these results indicate that the DNA-binding activities of Max and USF are regulated in a growth-dependent manner, despite their constitutive expression. Therefore, it is likely that posttranslational events increase the affinity of Max and USF for the cad E box during the transition from quiescence to a growing state. Finally, while c-Myc was not detectable in NIH 3T3 extracts used for examining DNA-binding activity, it was easily detectable in more stringently prepared lysates of NIH 3T3 nuclei. These observations indicate that recovery of c-Myc is sensitive to extraction procedures, as documented by others (19) . End-labeled, double-stranded oligonucleotide probes corresponding to cad promoter sequences ϩ55/ϩ75 were incubated with no extract (Ϫ) or nuclear extract from NIH 3T3 cells harvested at 0, 4, 8, or 12 h following stimulation of serum-starved cells. The 12-h extract was preincubated with a 50-fold molar excess of competitor DNAs prior to the addition of probe: no DNA (Ϫ), unlabeled probe DNA (wt; core sequence, CCACGTGG), the wild-type Ϫ81/ϩ83 cad promoter fragment (wtp; E-box core sequence, CCACGTGG), or the Ϫ81/ ϩ83 cad promoter fragment carrying a mutated E box (mp; E-box core sequence, a CtgcaGG). The 8-h extract was preincubated with either no antibody (Ϫ) or antisera specific to human USF, c-Myc, Max, or combinations thereof prior to the addition of probe. The DNA-protein complexes are labeled I, II, and IV; an additional complex, III, can be detected with K562 extract (data not shown). (B) Binding to the cad Sp1 sites. In the left panel, end-labeled double-stranded oligonucleotide probes corresponding to cad sequences Ϫ75/Ϫ43 were incubated with nuclear extract from NIH 3T3 cells harvested at 0, 4, 8, or 12 h following stimulation of serum-starved cells. The 12-h extract was preincubated with either no DNA (Ϫ) or a 50-fold molar excess of unlabeled probe DNA (ϩ) prior to the addition of radiolabeled probe. In the right panel, the 8-h extract was either not preincubated (Ϫ) or preincubated with antisera specific to human USF, c-Myc (14, 25, 52) . Both also interfere with CACGTG-driven reporter activity in proliferating cells (1, 37) . Moreover, since c-Myc does not associate with USF in vitro (10) , it is believed that Myc⌬Br and Myc⌬TAD do not sequester USF or other E-boxbinding factors that act independently of Max. Therefore, if G 1 /S-phase transactivation of the cad promoter requires a Max-associated factor, both Myc⌬Br and Myc⌬TAD should inhibit cad transcription with the same efficiency. However, since Myc⌬TAD:Max complexes can bind DNA, the Myc⌬TAD mutant could also efficiently occlude DNA-binding sites recognized by other E-box factors. If a non-Max-associated factor is primarily responsive for cad transcription, Myc⌬TAD will be a more effective inhibitor than Myc⌬Br. Similar experiments with USF dominant-negative proteins cannot be performed, since existing mutant proteins are known to interfere with E-box proteins that are not normal partners of the wild-type USF.
To determine if Myc⌬Br and Myc⌬TAD could inhibit cad transcription during the growth cycle, the Ϫ81/ϩ83 cad reporter was transfected into NIH 3T3 cells with plasmids expressing either no protein, Myc⌬Br, or Myc⌬TAD. On the basis of mutation of the E box in the Ϫ81/ϩ83 cad promoter background, these inhibitory proteins would reduce G 1 /Sphase activation to approximately 30% of the normal value if they were fully effective, provided, of course, that Max complexes were the primary contributors to growth-dependent transactivation. Figure 6B (right panel) represents the effect of the two mutant c-Myc expression plasmids on the induction of cad and another G 1 /S-phase-activated promoter, dhfr, during S phase. dhfr served as a negative control, since E2F has been shown to be the key regulator of dhfr transcription throughout the growth cycle (62). As expected, the level of dhfr induction was not significantly affected by coexpression of Myc⌬Br or Myc⌬TAD, indicating that expression of the mutants did not block cells from entering S phase. In contrast, the level of cad induction was reduced to 40 to 46% of the S-phase value observed in cells expressing the vector control plasmid. This magnitude of suppression by Myc⌬Br and Myc⌬TAD was similar to that seen by others in experiments with antisense c-Myc (54) . Furthermore, since both Myc⌬Br and Myc⌬TAD inhibited cad transcription to roughly the same degree, these data suggest that sequestration of Max, rather than binding-site occlusion, was the primary means of inhibition. The remaining fivefold induction in cad promoter activity was comparable to the fourfold induction of the E-box-mutated cad construct, cadEboxmt, in standard transfection experiments (Fig.  6B, left panel) . This comparison suggests that coexpression of c-Myc inhibitory mutants eliminated most of the G 1 /S-phase induction provided by the E-box element. Another E-boxbinding factor(s) may have provided the remaining induction at the G 1 /S-phase boundary, either as a normal regulator or as an opportunistic event in the absence of functional Maxassociated complexes. Alternatively, expression of Myc⌬Br or Myc⌬TAD under these conditions may not have completely blocked the function of relevant Max complexes. These data suggest, therefore, that the factor(s) which regulates cad transcription in response to growth signals acts through a Maxassociated complex that requires an E-box motif. Since the only Max partner known to transactivate transcription is the oncoprotein c-Myc, these data provide indirect evidence that c-Myc is involved in G 1 /S-phase activation of cad, a nucleotide biosynthetic gene. Of course, we cannot exclude the possibility that the Myc mutant proteins have unpredicted effects on other E-box proteins. However, further evidence that supports a role for c-Myc as a potential upstream activator of cad comes from cotransfection assays in which the Ϫ81/ϩ83 cad promoter construct was specifically activated threefold in the presence of plasmids expressing wild-type c-Myc versus no protein (data not shown). While this level of induction is modest, it is comparable to what has been reported for other c-Myc-activated genes (18, 59) .
DISCUSSION
In the course of studying the activation of the cad gene at the G 1 /S-phase boundary, we have demonstrated that the extended E-box sequence, CCACGTGG, which is located at ϩ65 in the cad promoter, is a growth-dependent response element. Nuclear proteins bind the cad E box in a growth cycle-dependent manner in NIH 3T3 cells, and mutation or deletion of the E box results in a dramatically less inducible promoter throughout the G 1 and S phases. Introducing the E box into various unresponsive promoters conferred growth-dependent transcriptional regulation, indicating that this element is both necessary and sufficient for G 1 /S-phase activation. In contrast, the E2F-like sequence which lies just 3Ј to the E box does not substantially contribute to cad transcription at the G 1 /S-phase boundary. This finding is consistent with earlier evidence that the cad promoter does not compete for E2F binding to the dhfr promoter (12) and that E2F does not transactivate cad in cotransfection assays (43) . An interesting feature of the growth-responsive E box in the hamster cad promoter is that it lies in a transcribed but untranslated region of the gene. We Fig. 1 . In the right panel, NIH 3T3 cells were transiently transfected with the expression plasmids LTR, LTR-Myc⌬Br (Myc⌬Br), or LTR-Myc⌬TAD (Myc⌬TAD) and either the cadϪ81/ϩ83 reporter or the dhfr reporter pWTluc. Cells were harvested in duplicate at 0, 12, 14, and 16 h following serum stimulation. Luciferase activity was measured at each time point and averaged between duplicate samples. S-phase induction was determined by dividing the maximum promoter activity in serum-stimulated cells by the level in serum-starved cells. The maximum induction obtained in four to eight independent experiments was averaged and is represented here. Error bars indicate the standard error between experiments. Basal promoter activity was comparable between promoter constructs and was at least 10-to 150-fold above the luciferase activity measured in mock-transfected cells.
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found that when the ϩ55/ϩ75 cad element was located downstream of ϩ1, greater S-phase activity was consistently supported than when this element was located upstream. E-box sequences are located downstream of the transcription initiation site in several c-Myc-activated genes, such as ECA39, p53, and murine odc, suggesting that perhaps this location may confer an as yet unexplained selectivity to the site. Since several cellular factors can affect transcription through the CCACGTGG motif, it is important to determine which E box-binding protein(s) modulates cad transcription. We showed that the binding activity of USF and Max and the protein levels of c-Myc changed in a growth cycle-dependent manner that closely correlates with cad promoter activity. Of these E-box-binding proteins, c-Myc is the only one shown previously to affect growth cycle progression, so it was a logical candidate for the regulator of cad transcription. Consistent with this hypothesis, c-Myc could activate transcription from the cad promoter, and cad transcription in S-phase was selectively inhibited by two dominant-negative c-Myc mutants that have been shown by others to decrease activity of c-Myc:Max heterodimers in both transcription and cellular transformation assays. This result suggests that the factor(s) which regulates the E-box-mediated increase in cad promoter activity at the G 1 /S-phase transition may act in the same pathway as c-Myc and/or Max but does not prove that these factors play a direct role. Although suppression of cad transcription by inhibitory c-Myc proteins was significant, it was not complete, suggesting that other E-box-binding factors may collectively contribute to cad promoter activity through the growth cycle. We do not believe that the other Max-associated factors, Mad and Mxi1, play a role in G 1 /S-phase activation of cad, because they have been implicated as differentiation-specific transcriptional repressors. It will be interesting, however, to determine in future studies whether Mad:Max and/or Mxi1:Max contributes to down-regulation of cad gene expression upon differentiation.
In summary, our studies involving promoter mutagenesis and DNA-binding assays indicate that E-box proteins are key regulators of cad transcription at the G 1 /S-phase transition. The use of inhibitory mutants suggests that a Max-associated complex contributes to growth-dependent regulation of cad. On the basis of well-established data about the various Max partner proteins to date, our observations point to c-Myc:Max heterodimers as potentially significant regulators of cad transcription during the transition from quiescence to a proliferative state. More direct studies are needed in vivo to precisely determine to what extent the other E-box-binding proteins, such as USF, contribute to G 1 /S-phase activation. Finally, the fact that c-Myc and E2F1 can both transform cells in culture and are both required for G 1 /S-phase progression raises the question whether c-Myc and E2F regulate checkpoints in the cell cycle via a linear pathway. Our finding that dominantnegative mutants of c-Myc do not interfere with activation of an E2F-regulated gene, dhfr, provides one piece of evidence that c-Myc is not an obligate, upstream component of the E2F signal transduction pathway leading to S phase.
